The Salsalate Capsules, cataloged under National Stock Number 6505-01-278-0522, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. Government technical data includes 3 specifications, cited from the U.S. Government catalog. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-278-0522 |
| Item Name | Salsalate Capsules |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Status | ACTIVE |
| Administration | ORAL |
| Features Provided | INDIVIDUALLY SEALED |
| Primary Container Type | STRIP |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Reference | Meaning |
|---|---|
| NDC00089-0151-16 | 3/9 Design control — primary reference 3m Company Health Care/mfg |
| DISALCID CAPSULES | 5/1 Secondary reference 3m Company Health Care/mfg |
NSN 6505-01-278-0522 is a Salsalate Capsules, classified under FSC 6505, Drugs and Biologicals. Status: active.
Key specifications for 6505-01-278-0522: Administration: ORAL; Features Provided: INDIVIDUALLY SEALED; Primary Container Type: STRIP; Special Features: ACTIVE MEDICAMENT MEDICINAL STRENGTH:750.000 MG SALSALATE ACTIVE INGREDIENT;PRIMARY CONTAINER CONTENT QTY:A/A;TOTAL PRIMARY CONTAINER QTY:A/A;100 CAPSULES PER PKG;. 3 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.